{"id":44194,"date":"2025-10-23T19:41:21","date_gmt":"2025-10-23T11:41:21","guid":{"rendered":"https:\/\/flcube.com\/?p=44194"},"modified":"2025-10-23T19:41:22","modified_gmt":"2025-10-23T11:41:22","slug":"vbp-11th-finalizes-389-participants-3-7-billion-doses-set-for-centralized-procurement","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=44194","title":{"rendered":"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement"},"content":{"rendered":"\n<p>The <strong>Office of the National Drug Joint Procurement<\/strong> (ONDJP) published the conclusive enterprise roster for the 11th batch of the country\u2019s centralized drug procurement program (VBP\u202f11th). A total of <strong>389 parent companies<\/strong> have been confirmed for bidding, a modest decline from the draft\u2011for\u2011comments stage, while the total demand remains steady at <strong>3.7\u202fbillion doses<\/strong> (excluding unspecified\u2011manufacturer requests).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-takeaways\"><strong>Key Takeaways<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Enterprise Participation<\/strong><\/td><td>389 confirmed parent companies<\/td><\/tr><tr><td><strong>Demand Volume<\/strong><\/td><td>3.7\u202fbillion doses (constant)<\/td><\/tr><tr><td><strong>Change vs Draft<\/strong><\/td><td>Slight reduction in participants<\/td><\/tr><tr><td><strong>Next Steps<\/strong><\/td><td>Contract awards expected in the coming weeks<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-procurement-context\"><strong>Procurement Context<\/strong><\/h3>\n\n\n\n<p>China\u2019s centralized procurement scheme, launched to streamline drug purchasing, cut costs, and improve access, has become a cornerstone of national health policy. VBP\u202f11th covers a broad therapeutic spectrum, from antibiotics to oncology agents, promising substantial savings for the public health system.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-enterprise-landscape\"><strong>Enterprise Landscape<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>389<\/strong> companies have met all eligibility criteria and registered for the bidding.<\/li>\n\n\n\n<li>The participant count fell modestly from the draft\u2011for\u2011comments list, reflecting tightened qualification standards.<\/li>\n\n\n\n<li>Major pharmaceutical manufacturers and distributors remain on board, preserving a competitive bidding environment.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-demand-outlook\"><strong>Demand Outlook<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>3.7\u202fbillion doses<\/strong> represent the total procurement volume for VBP\u202f11th, unchanged from earlier estimates.<\/li>\n\n\n\n<li>Demand is distributed across 12 therapeutic categories, with the largest volumes in chronic disease management and vaccines.<\/li>\n\n\n\n<li>Excluding \u201cdemand without specified manufacturers\u201d keeps the figure conservative, focusing on confirmed supply\u2011chain partners.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-market-implications\"><strong>Market Implications<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Price Competition<\/strong>: The large volume and narrow participant pool are likely to drive price reductions across multiple drug classes.<\/li>\n\n\n\n<li><strong>Supply\u2011Chain Consolidation<\/strong>: Smaller manufacturers may seek alliances or exit the bidding process to remain viable.<\/li>\n\n\n\n<li><strong>Policy Momentum<\/strong>: Successful execution of this batch reinforces the ONDJP\u2019s credibility and may pave the way for even larger procurement volumes in future cycles.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-forward-looking-statements\"><strong>Forward\u2011Looking Statements<\/strong><\/h2>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/file16256.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of file16256.\"><\/object><a id=\"wp-block-file--media-f7fb8061-1da8-4c71-8b0b-9ae076ddc481\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/file16256.pdf\">file16256<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/file16256.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f7fb8061-1da8-4c71-8b0b-9ae076ddc481\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for&#8230;<\/p>\n","protected":false},"author":1,"featured_media":44197,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[82],"class_list":["post-44194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-vbp-voluem-based-procurement"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for the 11th batch of the country\u2019s centralized drug procurement program (VBP\u202f11th). A total of 389 parent companies have been confirmed for bidding, a modest decline from the draft\u2011for\u2011comments stage, while the total demand remains steady at 3.7\u202fbillion doses (excluding unspecified\u2011manufacturer requests).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=44194\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement\" \/>\n<meta property=\"og:description\" content=\"The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for the 11th batch of the country\u2019s centralized drug procurement program (VBP\u202f11th). A total of 389 parent companies have been confirmed for bidding, a modest decline from the draft\u2011for\u2011comments stage, while the total demand remains steady at 3.7\u202fbillion doses (excluding unspecified\u2011manufacturer requests).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=44194\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-23T11:41:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-23T11:41:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2302.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement\",\"datePublished\":\"2025-10-23T11:41:21+00:00\",\"dateModified\":\"2025-10-23T11:41:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194\"},\"wordCount\":320,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2302.webp\",\"keywords\":[\"VBP (voluem-based procurement)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44194#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=44194\",\"name\":\"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2302.webp\",\"datePublished\":\"2025-10-23T11:41:21+00:00\",\"dateModified\":\"2025-10-23T11:41:22+00:00\",\"description\":\"The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for the 11th batch of the country\u2019s centralized drug procurement program (VBP\u202f11th). A total of 389 parent companies have been confirmed for bidding, a modest decline from the draft\u2011for\u2011comments stage, while the total demand remains steady at 3.7\u202fbillion doses (excluding unspecified\u2011manufacturer requests).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44194\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2302.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2302.webp\",\"width\":1080,\"height\":608,\"caption\":\"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44194#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement - Insight, China&#039;s Pharmaceutical Industry","description":"The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for the 11th batch of the country\u2019s centralized drug procurement program (VBP\u202f11th). A total of 389 parent companies have been confirmed for bidding, a modest decline from the draft\u2011for\u2011comments stage, while the total demand remains steady at 3.7\u202fbillion doses (excluding unspecified\u2011manufacturer requests).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=44194","og_locale":"en_US","og_type":"article","og_title":"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement","og_description":"The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for the 11th batch of the country\u2019s centralized drug procurement program (VBP\u202f11th). A total of 389 parent companies have been confirmed for bidding, a modest decline from the draft\u2011for\u2011comments stage, while the total demand remains steady at 3.7\u202fbillion doses (excluding unspecified\u2011manufacturer requests).","og_url":"https:\/\/flcube.com\/?p=44194","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-23T11:41:21+00:00","article_modified_time":"2025-10-23T11:41:22+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2302.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=44194#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=44194"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement","datePublished":"2025-10-23T11:41:21+00:00","dateModified":"2025-10-23T11:41:22+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=44194"},"wordCount":320,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=44194#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2302.webp","keywords":["VBP (voluem-based procurement)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=44194#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=44194","url":"https:\/\/flcube.com\/?p=44194","name":"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=44194#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=44194#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2302.webp","datePublished":"2025-10-23T11:41:21+00:00","dateModified":"2025-10-23T11:41:22+00:00","description":"The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for the 11th batch of the country\u2019s centralized drug procurement program (VBP\u202f11th). A total of 389 parent companies have been confirmed for bidding, a modest decline from the draft\u2011for\u2011comments stage, while the total demand remains steady at 3.7\u202fbillion doses (excluding unspecified\u2011manufacturer requests).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=44194#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=44194"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=44194#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2302.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2302.webp","width":1080,"height":608,"caption":"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=44194#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"VBP\u202f11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2302.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=44194"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44194\/revisions"}],"predecessor-version":[{"id":44198,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44194\/revisions\/44198"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/44197"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=44194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=44194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=44194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}